Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02XPB
|
|||
| Former ID |
DNC004926
|
|||
| Drug Name |
4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine
|
|||
| Synonyms |
benzylamine 6; CHEMBL179938; BDBM13580
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H23N3O2
|
|||
| Canonical SMILES |
COC1=C(C=CC(=C1)CNC2=CC=C(C=C2)C(=N)N)OCC3=CC=CC=C3
|
|||
| InChI |
1S/C22H23N3O2/c1-26-21-13-17(14-25-19-10-8-18(9-11-19)22(23)24)7-12-20(21)27-15-16-5-3-2-4-6-16/h2-13,25H,14-15H2,1H3,(H3,23,24)
|
|||
| InChIKey |
YPLDWUAEABIXKN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors. Bioorg Med Chem Lett. 2005 Feb 1;15(3):817-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.